Complete Response to Concurrent Triplet Therapy in Low‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Case Report
IJU Case Reports · 2026-07 · 9 (4)
DOI: 10.1002/iju5.70231 ↗Kurz gefasst
Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 17.07.2026. Verfasst von Takashi Fujita und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Gifu Prefectural Tajimi Hospital Tajimi Japan. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Triplet therapy with androgen deprivation therapy (ADT), an androgen receptor pathway inhibitor, and docetaxel improves survival in metastatic hormone‐sensitive prostate cancer (mHSPC), but its role in low‐volume disease remains unclear. Case Presentation A 68‐year‐old man presented with dysuria and a PSA increase to 34.49 ng/mL. Imaging revealed a prostate tumor extending into the bladder, right obturator lymph node metastasis, and a bone lesion. Biopsy showed Gleason score 5 + 5 prostate adenocarcinoma (cT4N1M1b low‐volume mHSPC). Concurrent triplet therapy with ADT, darolutamide, and docetaxel was initiated. PSA decreased to 0.1 ng/mL within 2 months, and imaging at 4.5 months demonstrated a radiological complete response. At the latest follow‐up (7 months), the PSA remained below 0.03 ng/mL without progression to CRPC.
Conclusion
Concurrent triplet therapy may achieve complete response in selected patients with aggressive low‐volume mHSPC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology Gifu Prefectural Tajimi Hospital Tajimi Japan.
ORCID-Profile: Takashi Fujita, Fumihiro Ito
Zitieren
APA
Fujita, T., Kobayashi, K., Hayashi, G., Kamijo, S., & Ito, F. (2026). Complete Response to Concurrent Triplet Therapy in Low‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Case Report. IJU Case Reports, 9(4). https://doi.org/10.1002/iju5.70231
Vancouver
Fujita T, Kobayashi K, Hayashi G, Kamijo S, Ito F. Complete Response to Concurrent Triplet Therapy in Low‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Case Report. IJU Case Reports. 2026;9(4). doi:10.1002/iju5.70231
BibTeX
@article{Fujita2026,
author = {Fujita, Takashi and Kobayashi, Koki and Hayashi, Gaku and Kamijo, Shunsuke and Ito, Fumihiro},
title = {Complete Response to Concurrent Triplet Therapy in Low‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Case Report},
journal = {IJU Case Reports},
year = {2026},
volume = {9},
number = {4},
doi = {10.1002/iju5.70231}
}
EUVIMED